SA Broadley

Could vitamin D be the answer to multiple sclerosis?
Mult Scler 2007 13: 825-826. [PDF] [References]  

RM Lucas, A-L. Ponsonby, AJ McMichael, I. van der Mei, C. Chapman, A. Coulthard, K. Dear, T. Dwyer, TJ Kilpatrick, MP Pender, B. Taylor, P. Valery, and D. Williams

Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function
Mult Scler 2007 13: 827-839. [Abstract] [PDF] [References]  

V. Lehmensiek, SD Süssmuth, G. Tauscher, J. Brettschneider, S. Felk, F. Gillardon, and H. Tumani

Cerebrospinal fluid proteome profile in multiple sclerosis
Mult Scler 2007 13: 840-849. [Abstract] [PDF] [References]  

K. Tanaka, T. Tani, M. Tanaka, T. Saida, J. Idezuka, M. Yamazaki, M. Tsujita, T. Nakada, K. Sakimura, and M. Nishizawa

Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions
Mult Scler 2007 13: 850-855. [Abstract] [PDF] [References]  

BM Herrera, MZ Cader, DA Dyment, JT Bell, GC DeLuca, CJ Willer, MR Lincoln, SV Ramagopalan, M. Chao, S-M. Orton, AD Sadovnick, and GC Ebers

Multiple sclerosis susceptibility and the X chromosome
Mult Scler 2007 13: 856-864. [Abstract] [PDF] [References]  

E. Leray, SP Morrissey, J. Yaouanq, M. Coustans, E. Le Page, J. Chaperon, and G. Edan

Long-term survival of patients with multiple sclerosis in West France
Mult Scler 2007 13: 865-874. [Abstract] [PDF] [References]  

SA Trip, PG Schlottmann, SJ Jones, W-Y. Li, DF Garway-Heath, AJ Thompson, GT Plant, and DH Miller

Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis
Mult Scler 2007 13: 875-879. [Abstract] [PDF] [References]  

Y. Zhang, RK Zabad, X. Wei, LM Metz, MD Hill, and JR Mitchell

Deep grey matter `black T2` on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis
Mult Scler 2007 13: 880-883. [Abstract] [PDF] [References]  

D. Soon, DJ Tozer, DR Altmann, PS Tofts, and DH Miller

Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes
Mult Scler 2007 13: 884-894. [Abstract] [PDF] [References]  

N. Garg, B. Weinstock-Guttman, K. Bhasi, J. Locke, and M. Ramanathan

An association between autoreactive antibodies and anti-interferon-ß antibodies in multiple sclerosis
Mult Scler 2007 13: 895-899. [Abstract] [PDF] [References]  

Judith Haas and Otto Roelf Hommes

A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis
Mult Scler 2007 13: 900-908. [Abstract] [PDF] [References]  

R.J. Fox, J.-C. Lee, and R.A. Rudick

Optimal reference population for the multiple sclerosis functional composite
Mult Scler 2007 13: 909-914. [Abstract] [PDF] [References]  

Marianne de Sèze, Alain Ruffion, Pierre Denys, Pierre-Alain Joseph, and Brigitte Perrouin-Verbe International Francophone Neuro-Urological expert study group (GENULF)

The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines
Mult Scler 2007 13: 915-928. [Abstract] [PDF] [References]  

K.I. Pakenham

The nature of caregiving in multiple sclerosis: development of the caregiving tasks in multiple sclerosis scale
Mult Scler 2007 13: 929-938. [Abstract] [PDF] [References]  

Hitomi Saito, Mariko Suzuki, Takehiro Asakawa, and Satoshi Kato

Retinopathy in a multiple sclerosis patient undergoing interferon-therapy
Mult Scler 2007 13: 939-940. [Abstract] [PDF] [References]  

E. Thouvenot, D. Hillaire-Buys, M.A. Bos-Thompson, V. Rigau, L. Durand, B. Guillot, and W. Camu

Erythema nodosum and glatiramer acetate treatment in relapsing-remitting multiple sclerosis
Mult Scler 2007 13: 941-944. [Abstract] [PDF] [References]  

S. Sahin, F.B. Aksungar, A.E. Topkaya, Z. Yildiz, U.T. Boru, S. Ayalp, and S. Karsidag

Increased plasma homocysteine levels in multiple sclerosis
Mult Scler 2007 13: 945-946. [PDF] [References]  

KC Simon, X. Yang, KL Munger, and A. Ascherio

Variation in the Epstein-Barr virus receptor, CR2, and risk of multiple sclerosis
Mult Scler 2007 13: 947-948. [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.